课题基金 / 基金详情

Molecular mechanisms of chromatin and epigenetic regulation

Molecular mechanisms of chromatin and epigenetic regulation
染色质和表观遗传调控的分子机制
批准号:
10229452
负责人:
Scott Rothbart
金额:
$47.5万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-08-15 至 2022-07-31

项目摘要

项目成果

Scott Rothbart的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY The long-term goal of our research program is to define molecular mechanisms regulating chromatin modification signaling. We are particularly interested in understanding the complex relationship between DNA methylation and histone posttranslational modifications; two key epigenetic regulators of genome accessibility and function. Within this broad framework, we question 1) how are the writers and erasers of chromatin modifications regulated, 2) how do nuclear proteins and their complexes interface with (i.e., read) epigenetic marks to perform their chromatin regulatory functions, and 3) how does deregulation of chromatin signaling contribute to human disease? Our current studies are focused on UHRF1, an E3 ubiquitin ligase that is the cornerstone of a pathway responsible for maintaining a major portion of the DNA methylation found in mammalian cells. We recently showed that UHRF1 functions as a key regulator of DNA methylation inheritance through its interconnected reader and writer activities toward histone H3. While details of how UHRF1 performs its regulatory function are beginning to be uncovered, major gaps in knowledge exist in our basic molecular understanding of DNA methylation regulation and the role of UHRF1 in this process. Projects in the lab under this framework will question 1) how does UHRF1 interact with and modify chromatin, 2) what is the relationship between UHRF1, DNA methylation, and genome accessibility, 3) what is the role of histone ubiquitination in DNA methylation regulation, and 4) how does the structurally related protein UHRF2 regulate DNA methylation? Through a multidisciplinary and collaborative research program that leverages strengths in biochemical, biophysical, structural, genomic, proteomic, and cell-based studies of chromatin and epigenetic regulation, we hope to translate basic knowledge of epigenetic mechanism into therapeutic benefit.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1007/978-1-0716-1294-1_7
发表时间: 2021
期刊: Methods in molecular biology (Clifton, N.J.)
影响因子: --
作者: [Tiedemann RL, Eden HE, Huang Z, Robertson KD, Rothbart SB]
通讯作者: Rothbart SB
Chromatin structure and its chemical modifications regulate the ubiquitin ligase substrate selectivity of UHRF1.
染色质结构及其化学修饰调节 UHRF1 的泛素连接酶底物选择性。
DOI: 10.1073/pnas.1806373115
发表时间: 2018-08-28
期刊: Proceedings of the National Academy of Sciences of the United States of America
影响因子: 11.1
作者: [Vaughan RM, Dickson BM, Whelihan MF, Johnstone AL, Cornett EM, Cheek MA, Ausherman CA, Cowles MW, Sun ZW, Rothbart SB]
通讯作者: Rothbart SB
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
Epigenetic Synergy Between DNMT and EZH1/2 Inhibitors for Therapy in Solid Tumors
Molecular mechanisms of chromatin and epigenetic regulation
  • 批准号:
    9381318
  • 项目类别:
  • 资助金额:
    $47.5万
  • 财政年份:
    2017
  • 负责人:
    Scott Rothbart
  • 依托单位:
海外基金